NeuraLight
PrivateLast Round
Series A
May 24, 2022
Total Funding Raised
$30.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeuraLight operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Series A round in May 2022.
NeuraLight is a digital health company that provides an AI-driven platform designed to assist patients with neurological disorders by utilizing a proprietary oculometric database for enhanced diagnosis and monitoring through standard smartphones or webcams.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Medical AI, Precision Medicine, Computer Vision
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuraLight Comparables
Compare NeuraLight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altoida, Inc. | 83% | |
| Innodem Neurosciences | 82% | |
| Koneksa Health | 78% |
For institutional investors. Book with your work email.
NeuraLight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 24, 2022 | ||||
| Seed | Oct 29, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuraLight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MS&AD Ventures | Seed |
| Breyer Capital | Series A |
| VSC Ventures | Seed, Series A |
| Global Founders Capital | Seed |
| Tuesday Capital | Seed |
| Koch Disruptive Technologies | Series A |
| Samsung NEXT Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 43% MoM, reaching 4.7K.
- Feb 26, 2026
Professor Olivier Rascol appointed Chair of the Scientific Advisory Board.
For institutional investors. Book with your work email.
NeuraLight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuraLight's valuation, stock price, and market status.
Is NeuraLight a public or private company?
NeuraLight is a private company.
What is the current stock price of NeuraLight?
NeuraLight is a private company, so its shares have no public market price. Caplight tracks NeuraLight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuraLight worth (valuation)?
Valuation information for NeuraLight is not publicly available.
Can I buy NeuraLight stock?
NeuraLight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuraLight's last funding round?
NeuraLight's most recent funding round was Series A on May 24, 2022.
Who are the main investors in NeuraLight?
Key investors in NeuraLight include MS&AD Ventures, Tuesday Capital, Koch Disruptive Technologies, Koch Disruptive Technologies, Kli Capital.
Will NeuraLight IPO soon?
No public IPO plans have been announced for NeuraLight.
How can I track NeuraLight secondary market activity?
Caplight tracks bids, offers, and trades in NeuraLight's shares on secondary markets.